Skip to contentB
Bio-Path Holdings, Inc.
B
BPTHBio-Path Holdings, Inc. Q3 2013 · 10-Q
Revenue$0.00$0.00— vs Q3 2012 Net Income-$1.39M-$1.39MN/M vs Q3 2012 EPS Diluted-$0.02-$0.02N/M vs Q3 2012 Operating Income-$1,393,728N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Path Holdings, Inc. · CIK 1133818 · Engraved from SEC EDGAR
derived
ended Sep 30, 2013 · filed Nov 14, 2013 · 45 d after period end